LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN

150MG/37,5MG/200MG TBL FLM 30

SÚKL code 0214877
Name of the product LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150 MG/37,5 MG/200 MG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN
Supplement 150MG/37,5MG/200MG TBL FLM 30
Strenght 150MG/37,5MG/200MG
Pharmaceutical form Film-coated tablet
Package 30
Route Oral use
Language of the pack Czech
Wrap type Tablet container
Legal status na lékařský předpis
Active substance LEVODOPA (LEVODOPUM)
ENTACAPONE (ENTACAPONUM)
CARBIDOPA MONOHYDRATE (CARBIDOPUM MONOHYDRICUM)
ATC group N04BA03
ATC group name LEVODOPA, INHIBITOR DEKARBOXYLASY A INHIBITOR COMT

Marketing authorisation information

Registration Number 27/ 008/16-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 28. 02. 2019
MA Holder Generics [UK] Limited, Potters Bar
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list